Cite
Clarithromycin as a "repurposing drug" against MALT lymphoma.
MLA
Ferreri, Andrés J. M., et al. “Clarithromycin as a ‘Repurposing Drug’ against MALT Lymphoma.” British Journal of Haematology, vol. 182, no. 6, Sept. 2018, pp. 913–15. EBSCOhost, https://doi.org/10.1111/bjh.14878.
APA
Ferreri, A. J. M., Cecchetti, C., Kiesewetter, B., Sassone, M., Calimeri, T., Perrone, S., Ponzoni, M., & Raderer, M. (2018). Clarithromycin as a “repurposing drug” against MALT lymphoma. British Journal of Haematology, 182(6), 913–915. https://doi.org/10.1111/bjh.14878
Chicago
Ferreri, Andrés J M, Caterina Cecchetti, Barbara Kiesewetter, Marianna Sassone, Teresa Calimeri, Salvatore Perrone, Maurilio Ponzoni, and Markus Raderer. 2018. “Clarithromycin as a ‘Repurposing Drug’ against MALT Lymphoma.” British Journal of Haematology 182 (6): 913–15. doi:10.1111/bjh.14878.